Advertisement
Advertisement
U.S. Markets close in 3 hrs 45 mins
Advertisement
Advertisement
Advertisement
Advertisement

BIMI International Medical Inc. (BIMI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5737-0.0049 (-0.85%)
As of 12:11PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5786
Open0.5800
Bid0.5731 x 1000
Ask0.5788 x 1300
Day's Range0.5625 - 0.5800
52 Week Range0.5600 - 2.8100
Volume132,533
Avg. Volume281,016
Market Cap14.131M
Beta (5Y Monthly)-0.23
PE Ratio (TTM)N/A
EPS (TTM)-0.2500
Earnings DateNov 15, 2021 - Nov 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    BIMI International Medical Inc. Signs Stock Purchase Agreement to Acquire Chongqing Zhuoda Pharmaceutical Co., Ltd.

    NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider in China, today announced that it entered into a Stock Purchase Agreement (the “Agreement”) on September 10, 2021, to acquire Chongqing Zhuoda Pharmaceutical Co., Ltd. (“Zhuoda”), a wholesale supplier of pharmaceuticals and medical equipment, including over 1,220 pharmaceutical products, thousands of Chinese herbal medicines an

  • GlobeNewswire

    BIMI International Medical Inc. Enters Into A MOU to Acquire Chongqing Zhuoda Pharmaceutical Co, Ltd.

    NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider in China, today announced the signing of a Memorandum of Understanding (“MOU”) on July 30, 2021 to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd.(“Zhuoda”). Pursuant to the MOU, BIMI and the owners of Zhouda have agreed to sign a stock purchase agreement (“Agreement”) after completing the relevant assessment and evaluation of

  • GlobeNewswire

    BIMI International Medical Inc. Announces Appointment of New Chief Financial Officer

    NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider in China, today announced the appointment of Amy Xue as the Company’s new Chief Financial Officer, effective July 15, 2021. Xue is a CPA and ACCA certified accountant and experienced senior finance executive. Prior to her appointment as BIMI’s Chief Financial Officer, she served as CFO at iFresh, Inc. (NASDAQ:IFMK) between March

Advertisement
Advertisement